A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| CD206/MRC1 Antibody [K13P18] | CD206/MRC1 Antibody [K13P18]. Group: Antibodies. Alternative Names: Macrophage mannose receptor 1, MMR, C-type lectin domain family 13 member D, C-type lectin domain family 13 member D-like, Human mannose receptor (hMR), Macrophage mannose receptor 1-like protein 1, CD206, MRC1, CLEC13D, CLEC13DL, MRC1L1. CAS No. Pack Sizes: 20uL. Product ID: F4083. Storage Conditions: -20°C (avoid freeze-thaw cycles), 2 years. |  United States; Europe |
| CD 2314 | CD 2314 is a potent and selective RARβ receptor agonist (Kd = 145 and >3760 nM for RARβ and RARα receptors, respectively). Synonyms: CD-2314; CD 2314; CD2314; 5-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)-3-thiophenecarboxylic acid. Grade: ≥98% by HPLC. CAS No. 170355-37-0. Molecular formula: C23H24O2S. Mole weight: 364.5. |  |
| CD 2314 | CD 2314. Group: Biochemicals. Grades: Purified. CAS No. 170355-37-0. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. |  Worldwide |
| CD235 | CD235 is a structurally similar analogue of CD161, which is a potent and orally bioavailable inhibitor of BET bromodomain. Synonyms: 7-(3,5-Dimethyl-1,2-oxazol-4-yl)-4-(6-fluoro-4-quinolinyl)-6-methoxy-2-methyl-9H-pyrimido[4,5-b]indole; 9H-Pyrimido[4,5-b]indole, 7-(3,5-dimethyl-4-isoxazolyl)-4-(6-fluoro-4-quinolinyl)-6-methoxy-2-methyl-. Grade: ≥95%. CAS No. 1627716-57-7. Molecular formula: C26H20FN5O2. Mole weight: 453.47. | |
| CD2665 | CD2665 is an orally active and selective RAR-β,γ antagonist, with Kd values of 306 nM, 110 nM for RAR-β and RAR-γ, repectively[1][3]. Uses: Scientific research. Category: Signaling pathways. CAS No. 170355-78-9. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-107437. |  |
| CD 2665 | CD 2665 is a selective RARβ and RARγ antagonist (KD = 110, 306 and > 1000 nM for RARγ, RARβ and RARα respectively) with no activity at RXRα. CD 2665 is used to abrogate retinoic acid-induced apoptosis, proliferation and differentiation of sebocyte growth. Synonyms: CD2665; CD 2665; CD-2665. 4-[6-[(2-Methoxyethoxy)methoxy]-7-tricyclo[3.3.1.13,7]dec-1-yl-2-naphthalenyl)benzoic acid. Grade: ≥98% by HPLC. CAS No. 170355-78-9. Molecular formula: C31H34O5. Mole weight: 486.6. | |
| CD 2665 | CD 2665. Group: Biochemicals. Grades: Purified. CAS No. 170355-78-9. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| Cd2+-exporting ATPase | A P-type ATPase that undergoes covalent phosphorylation during the transport cycle. This enzyme occurs in protozoa, fungi and plants. Group: Enzymes. Enzyme Commission Number: EC 3.6.3.3. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4667; Cd2+-exporting ATPase; EC 3.6.3.3. Cat No: EXWM-4667. |  |
| CD-3 | CD-3 (Part#: 1090) |  |
| CD31 (PECAM-1) Antibody [M18G16] | CD31,CD31 (PECAM-1),CD31 / PECAM-1,PECAM-1. Group: Antibodies. Alternative Names: CD31,PECAM-1. Pack Sizes: 20uL. Product ID: F0131. Storage Conditions: -20°C (avoid freeze-thaw cycles), 2 years. | United States; Europe |
| CD 3254 | CD 3254. Group: Biochemicals. Grades: Purified. CAS No. 196961-43-0. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| CD 3254 | CD 3254 is a selective RXRα agonist with no activity at RARα, RARβ or RARγ receptors. Synonyms: CD3254; CD 3254; CD-3254. 3-[4-Hydroxy-3-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)phenyl]-2-propenoic acid. Grade: ≥97% by HPLC. CAS No. 196961-43-0. Molecular formula: C24H28O3. Mole weight: 364.48. | |
| CD33 splicing modulator 1 | CD33 splicing modulator 1 (Compound 1) is a CD33 splicing modulator. CD33/Siglec 3 is a myeloid lineage cell surface receptor that is known to regulate microglia activity. CD33 splicing modulator 1 increases exon 2 skipping in cellular mRNA pools. CD33 splicing modulator 1 has the potential for the research of neurodegenerative disease including Alzheimer's disease[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2762547-05-5. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-144399. | |
| CD34+ Cells Targeted SM102 LNP-EGFP mRNA (m1Ψ) | This product is a LNP prepared from SM102 as the ionizable lipid and modified with CD34 antibody. It's specifically designed for targeted delivery of EGFP mRNA to CD34 positive cells. EGFP mRNA, a common fluorescence reporter, translates into enhanced green fluorescent protein, which exhibits an excitation wavelength of 488 nm and emission at 507 nm. The loaded EGFP mRNA is modified with N1-methyl-pseudouridine to enhance expression and reduce immunogenicity. It is only for research purposes. Group: Lipid nanoparticle. |  |
| CD38 inhibitor 1 | CD38 inhibitor 1 (compound 78c) is a potent CD38 inhibitor with IC50s of 7.3 nM and 1.9 nM for hCD38 and mouse CD38[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1700637-55-3. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 250 mg; 500 mg. Product ID: HY-123999. | |
| CD38 inhibitor 1 | CD38 inhibitor 1 is a potent CD38 inhibitor. Synonyms: CD38-IN-78c; MDK-7553. CAS No. 1700637-55-3. Molecular formula: C22H27N3O3S. Mole weight: 413.53. | |
| CD38 inhibitor 1 (compound 78c) | CD38 inhibitor 1 (compound 78c, CD38-IN-78c, MDK-7553) is a potent inhibitor of CD38 with IC50 of 7.3 nM and 1.9 nM for human CD38 and mouse CD38, respetively. Group: Inhibitors. Alternative Names: CD38-IN-78c, MDK-7553. CAS No. 1700637-55-3. Pack Sizes: 5mg. Product ID: S8960. Formula: C22H27N3O3S. Smiles: CN1C2=C(C=C(C=C2)C3=CN=CS3)C(=CC1=O)NC4CCC(CC4)OCCOC. Storage Conditions: 3 years -20°C powder. | United States; Europe |
| CD39-IN-1 | CD39-IN-1 is a selective CD39 inhibitor with an IC50 value of 68.7 nM. CD39-IN-1 exerts antiproliferative effects on tumor cells and shows low toxicity to normal cell lines. CD39-IN-1 inhibits CD39-mediated eATP hydrolysis in the ATP-adenosine pathway. CD39-IN-1 is applicable for tumor-related research[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 3097380-98-5. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-174341. | |
| CD-4 | CD-4 (Part#: 1095) | |
| CD40-TRAF6 inhibitor | A CD40-TRAF6 interaction inhibitor. Synonyms: 3-[(2,5-Dimethylphenyl)amino]-1-phenyl-2-propen-1-one. CAS No. 433249-94-6. Molecular formula: C17H17NO. Mole weight: 251.32. | |
| CD437 | CD437 is a selective Retinoic Acid Receptor γ (RARγ) agonist. Uses: Scientific research. Category: Signaling pathways. Alternative Names: AHPN. CAS No. 125316-60-1. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-100532. | |
| CD 437 | CD 437. Group: Biochemicals. Grades: Purified. CAS No. 125316-60-1. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| CD532 | CD532 is a potent Aurora A kinase inhibitor with an IC50 of 45 nM. CD532 has the dual effect of blocking Aurora A kinase activity and driving degradation of MYCN. CD532 also can directly interact with AURKA and induces a global conformational shift. CD532 can be used for the research of cancer[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1639009-81-6. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg. Product ID: HY-112273. | |
| CD532 hydrochloride | CD532 hydrochloride is a potent Aurora A kinase inhibitor with an IC50 of 45 nM. CD532 hydrochloride has the dual effect of blocking Aurora A kinase activity and driving degradation of MYCN. CD532 hydrochloride can also directly interact with AURKA and induces a global conformational shift. Synonyms: CD532 (hydrochloride); CD532 hydrochloride; EX-A8075A; HY-112273A; MS-30172; CS-0202740; 2926498-81-7. Grade: 99%. Molecular formula: C26H26ClF3N8O. Mole weight: 558.99. | |
| CD59 glycoprotein precursor (106-114) | CD59 glycoprotein precursor (106-114) is a peptide derived from CD59 glycoprotein precursor which is a potent inhibitor of the complement membrane attack complex (MAC) action. CD59 glycoprotein is involved in signal transduction for T-cell activation complexed to a protein tyrosine kinase. Synonyms: HRF-20 (106-114); Membrane attack complex inhibition factor (106-114). | |
| CD63 Antibody [N10M7] | CD63 Antibody [N10M7]. Group: Antibodies. CAS No. Pack Sizes: 20uL. Product ID: F0983. Storage Conditions: -20°C (avoid freeze-thaw cycles), 2 years. | United States; Europe |
| CD68 Antibody [M20C19] | CD68,CD68/SR-D1. Group: Antibodies. Alternative Names: CD68, Macrosialin, Cd68. CAS No. Pack Sizes: 20uL. Product ID: F3794. Storage Conditions: -20°C (avoid freeze-thaw cycles), 2 years. | United States; Europe |
| CD73-IN-1 | CD73-IN-11 is a CD73 inhibitor with an IC50 of ≤316.23 nM for the human enzyme in a cell-free assay. It can be used in cancer treatment. (Extracted from patent WO 2017153952 A1, example 80). Synonyms: VPS34 inhibitor; 5-[N-(2-Cyclopropyl-6-indolyl)sulfamoyl]-2-hydroxybenzamide; CD73 inhibitor 1; Benzamide, 5-[[(2-cyclopropyl-1H-indol-6-yl)amino]sulfonyl]-2-hydroxy-. Grade: ≥98%. CAS No. 2132396-40-6. Molecular formula: C18H17N3O4S. Mole weight: 371.41. | |
| CD73-IN-2 | CD73-IN-2 is a potent CD73 inhibitor with an IC50 of 0.09 nM. Synonyms: ((((2R,3S,4R,5R)-5-((6-chloro-4-(cyclopentylamino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)methyl)phosphonic acid. Molecular formula: C17H25ClN5O7P. Mole weight: 477.84. | |
| CD73-IN-4 | CD73-IN-4 is a potent and selective methylenephosphonic acid CD73 inhibitor with an IC50 of 2.6 nM for human. It has potential in cancer immunology research. Synonyms: 1H-Pyrazolo[3,4-d]pyrimidin-4-amine, 6-chloro-N-cyclopentyl-1-[5-O-(phosphonomethyl)-β-D-ribofuranosyl]-; 6-Chloro-N-cyclopentyl-1-[5-O-(phosphonomethyl)-β-D-ribofuranosyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine. Grade: ≥97%. CAS No. 2216764-29-1. Molecular formula: C16H23ClN5O7P. Mole weight: 463.81. | |
| CD73-IN-5 | CD73-IN-5 is a potent and selective non-nucleotide small molecule CD73 inhibitor with an IC50 of 19 nM. Synonyms: Benzonitrile, 4-[[5-[4-fluoro-1-(1H-indazol-6-yl)-1H-benzotriazol-6-yl]-1H-pyrazol-1-yl]methyl]-. CAS No. 2412019-99-7. Molecular formula: C24H15FN8. Mole weight: 434.43. | |
| CD9 Antibody [J21F10] | CD9 Antibody [J21F10]. Group: Antibodies. Pack Sizes: 20ul. Product ID: F1178. Storage Conditions: -20°C (avoid freeze-thaw cycles), 2 years. | United States; Europe |
| CDAP | CDAP is an organic cyanylating reagent that can be used for preparation of solid phase affinity reagents, modification of protein thiols and nucleotide delivery. CDAP also activates polysaccharides with a variety of chemical properties. CDAP can be used to prepare conjugate vaccines and other immune reagents[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 59016-56-7. Pack Sizes: 10 mM * 1 mL in DMSO; 100 mg; 250 mg; 500 mg; 1 g; 5 g. Product ID: HY-W012184. | |
| Cdc25A (80-93) (human) | Cdc25A abundance fluctuates periodically during the cell division cycle and is mainly regulated by the ubiquitin-proteasome system, through the action of two ubiquitin ligase complexes, which later promote complex/cyclosome and Skp1/Cul1/F-box proteins. Due to the presence of the destruction motif (KEN-box) in Cdc25A, ubiquitination and degradation occur at the mitotic outlet and G1, while phosphorylation events modulate the stability of Cdc25A protein in the S phase, both in undisturbed cells and in cells exposed to DNA damage agents or DNA replication inhibitors. Synonyms: H-Thr-Asp-Ser-Gly-Phe-Cys-Leu-Asp-Ser-Pro-Gly-Pro-Leu-Asp-OH. Grade: ≥95%. CAS No. 851538-67-5. Molecular formula: C60H90N14O24S. Mole weight: 1423.52. | |
| Cdc7-IN-1 | Cdc7-IN-1 (Compound 13) is a highly potent, selective and ATP competitive inhibitor of Cdc7 kinase, with an IC50 value of 0.6 nM at 1 mM ATP and with slow off-rate characteristics. Cdc7-IN-1 potently inhibits Cdc7 activity in cancer cells, and effectively induces cell death[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1402055-25-7. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-101523. | |
| Cdc7-IN-1 | Cdc7-IN-1 is a highly potent, selective and ATP competitive Cdc7 kinase inhibitor, with an IC50 of 0.6 nM at 1 mM ATP and a slow deceleration characteristic. It can effectively inhibit the activity of Cdc7 in cancer cells and induce cell death. Synonyms: Ethyl (5Z)-2-[(2-chlorophenyl)amino]-4-oxo-5-(1H-pyrrolo[2,3-b]pyridin-3-ylmethylene)-4,5-dihydro-3-furancarboxylate; 3-Furancarboxylic acid, 2-[(2-chlorophenyl)amino]-4,5-dihydro-4-oxo-5-(1H-pyrrolo[2,3-b]pyridin-3-ylmethylene)-, ethyl ester, (5Z)-. Grade: ≥99%. CAS No. 1402055-25-7. Molecular formula: C21H16ClN3O4. Mole weight: 409.82. | |
| Cdc7-IN-3 | Cdc7-IN-3, a potent inhibitor of Cdc7 kinase, is a serine-threonine protein kinase enzyme that is required for the initiation of DNA replication during the cell cycle. (Extracted from patent WO2019165473A1, compound I-B). Synonyms: Isopropyl (5Z)-2-(4-morpholinylamino)-4-oxo-5-(1H-pyrrolo[2,3-b]pyridin-3-ylmethylene)-4,5-dihydro-3-furancarboxylate; 3-Furancarboxylic acid, 4,5-dihydro-2-(4-morpholinylamino)-4-oxo-5-(1H-pyrrolo[2,3-b]pyridin-3-ylmethylene)-, 1-methylethyl ester, (5Z)-. Grade: ≥95%. CAS No. 1402057-87-7. Molecular formula: C20H22N4O5. Mole weight: 398.41. | |
| Cdc7-IN-4 | Cdc7-IN-4, a potent inhibitor of Cdc7 kinase, is a serine-threonine protein kinase enzyme that is required for the initiation of DNA replication during the cell cycle. (Extracted from patent WO2019165473A1, compound I-C). Synonyms: Isopropyl (5Z)-4-oxo-5-(1H-pyrrolo[2,3-b]pyridin-3-ylmethylene)-2-{[4-(2,2,2-trifluoroethyl)-1-piperazinyl]amino}-4,5-dihydro-3-furancarboxylate; 3-Furancarboxylic acid, 4,5-dihydro-4-oxo-5-(1H-pyrrolo[2,3-b]pyridin-3-ylmethylene)-2-[[4-(2,2,2-trifluoroethyl)-1-piperazinyl]amino]-, 1-methylethyl ester, (5Z)-. Grade: ≥97%. CAS No. 1402059-21-5. Molecular formula: C22H24F3N5O4. Mole weight: 479.45. | |
| Cdc7-IN-5 | Cdc7-IN-5, a potent inhibitor of Cdc7 kinase, is a serine-threonine protein kinase enzyme that is required for the initiation of DNA replication during the cell cycle. (Extracted from patent WO2019165473A1, compound I-B). Synonyms: Ethyl (5Z)-2-(7-methoxy-3,4-dihydro-2(1H)-isoquinolinyl)-4-oxo-5-(1H-pyrrolo[2,3-b]pyridin-3-ylmethylene)-4,5-dihydro-3-furancarboxylate; 3-Furancarboxylic acid, 2-(3,4-dihydro-7-methoxy-2(1H)-isoquinolinyl)-4,5-dihydro-4-oxo-5-(1H-pyrrolo[2,3-b]pyridin-3-ylmethylene)-, ethyl ester, (5Z)-. Grade: ≥95%. CAS No. 1402057-86-6. Molecular formula: C25H23N3O5. Mole weight: 445.47. | |
| Cdc7-IN-6 | Cdc7-IN-6 is a potent Cdc7 kinase inhibitor (IC50 = 4 nM) with antitumor activity. (Extracted from patent WO2019165473A1, compound I-D). Synonyms: AS-0141; Ethyl (5Z)-4-oxo-5-(1H-pyrrolo[2,3-b]pyridin-3-ylmethylene)-2-{[4-(2,2,2-trifluoroethyl)-1-piperazinyl]amino}-4,5-dihydro-3-furancarboxylate; 3-Furancarboxylic acid, 4,5-dihydro-4-oxo-5-(1H-pyrrolo[2,3-b]pyridin-3-ylmethylene)-2-[[4-(2,2,2-trifluoroethyl)-1-piperazinyl]amino]-, ethyl ester, (5Z)-. Grade: ≥97%. CAS No. 1402057-88-8. Molecular formula: C21H22F3N5O4. Mole weight: 465.43. | |
| Cdc7-IN-7 | Cdc7-IN-7, a potent inhibitor of Cdc7 kinase, is a serine-threonine protein kinase enzyme that is required for the initiation of DNA replication during the cell cycle. (Extracted from patent WO2019165473A1, compound I-E). Synonyms: Cyclopropylmethyl (5Z)-2-(4-morpholinylamino)-4-oxo-5-(1H-pyrrolo[2,3-b]pyridin-3-ylmethylene)-4,5-dihydro-3-furancarboxylate; 3-Furancarboxylic acid, 4,5-dihydro-2-(4-morpholinylamino)-4-oxo-5-(1H-pyrrolo[2,3-b]pyridin-3-ylmethylene)-, cyclopropylmethyl ester, (5Z)-. Grade: ≥97%. CAS No. 1402059-17-9. Molecular formula: C21H22N4O5. Mole weight: 410.42. | |
| CDC801 | A potent, orally active and dual inhibitor of phosphodiesterase 4 (PDE4) (IC50= 1.1 μM) and tumor necrosis factor-α (TNF-α) (IC50= 2.5 μM). Synonyms: CDC801; CDC 801; CDC-801; 3-(3-cyclopentyloxy-4-methoxyphenyl)-3-(1,3-dioxoisoindol-2-yl)propanamide. CAS No. 192819-27-5. Molecular formula: C23H24N2O5. Mole weight: 408.45. | |
| CDD0102 | CDD0102 is a selective M1 agonist which stimulated the secretion of APP from CHO-K1 cells expressing M1 receptors and penetrated into the brain following i.p. administration in rodents. Synonyms: CDD0102; CDD 0102; CDD-0102; 3-ethyl-5-(1,4,5,6-tetrahydropyrimidin-5-yl)-1,2,4-oxadiazole; 5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine; CDD-0102A. CAS No. 146422-58-4. Molecular formula: C8H12N4O. Mole weight: 180.21. | |
| CDD-1653 | CDD-1653 is a potent and selective BMPR2 inhibitor (IC50=2.8 nM). CDD-1653 reduces the ability of ATP to bind to the kinase domain of BMPR2, thereby affecting the phosphorylation of SMAD1/5/8 transcription factors, which play a key role in the BMP signaling pathway. CDD-1653 can be used to study diseases related to the BMP signaling pathway[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 3034216-44-6. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-164145. | |
| CDD-2789 | CDD-2789 is a potent and selective ALK2 inhibitor with an IC50 0.54 μM and a Kd of 2.1 nM, respectively. CDD-2789 exhibits >120-fold selectivity over ALK3/5/6. CDD-2789 reduces activin A- and BMP2-induced SMAD1/5 phosphorylation in fibroblasts. CDD-2789 can be used for ALK2-related cancer research[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 3052084-77-9. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-173149. | |
| CDD-2807 | CDD-2807 is an inhibitor for serine/threonine kinase 33 (STK33) with IC50 of 9.2 nM. CDD-2807 exhibits no significant toxicity in mice and can cross the blood-testis barrier without accumulating in the brain. CDD-2807 induces a reversible contraceptive effect and has potential for the development of the male contraceptive[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 3086536-23-1. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-162565. | |
| CDD3505 | CDD3505 is an inducer of hepatic cytochrome P450IIIA (CYP3A) activity that elevates high density lipoprotein cholesterol (HDL). Uses: Cytochrome p-450 enzyme inhibitors. Synonyms: 4-Nitro-1-trityl-1H-imidazole; 1-Trityl-4-nitroimidazole. CAS No. 173865-33-3. Molecular formula: C22H17N3O2. Mole weight: 355.39. | |
| CDDD3602 | Tematropium, a neurological agent, is a soft anticholinergic drug. Synonyms: Tematropium; HGP6; Tematropium methylsulfate; Tematropium metilsulfate; 3alpha-Hydroxy-8-methyl-1alphaH,5alphaH-tropanium methyl sulfate (salt), (±)-ethyl hydrogen phenylmalonate; 8-Azoniabicyclo(3.2.1)octane, 3-(3-ethoxy-1,3-dioxo-2-phenylpropoxy)-8,8-dimethyl-, endo-(±)-, methyl sulfate; (3-endo)-3-[(3-Ethoxy-3-oxo-2-phenylpropanoyl)oxy]-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane methyl sulfate. Grade: ≥95%. CAS No. 113932-41-5. Molecular formula: C21H31NO8S. Mole weight: 457.54. | |
| CDDO-2-P-Im | CDDO-2-P-Im is an orally active inhibitor of necroptosis. Synonyms: CDDO-2P-Im. Grade: 98%. CAS No. 1883650-96-1. Molecular formula: C39H46N4O3. Mole weight: 618.8. | |
| CDDO-3-P-Im | CDDO-3-P-Im is an orally active inhibitor of necroptosis. Synonyms: CDDO-3P-Im. Grade: 98%. CAS No. 1883650-95-0. Molecular formula: C39H46N4O3. Mole weight: 618.8. | |
| CDDO-biotin | CDDO-biotin is an IKKβ inhibitor with cancer cell inhibitory activity. CDDO-biotin directly interacts with and oxidizes Cys-179 in the activation loop of IKKβ, forming an adduct with wild-type IKKβ. CDDO-biotin can be used in the research of myeloid leukemia, osteosarcoma, multiple myeloma, lung cancer, breast cancer and pancreatic cancer[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 3110422-01-7. Pack Sizes: 5 mg; 10 mg; 25 mg. Product ID: HY-186167. | |
| CDDO-dhTFEA | CDDO-dhTFEA (RTA dh404) is a synthetic oleanane triterpenoid compound which potently activates Nrf2 and inhibits the pro-inflammatory transcription factor NF-κB[1]. CDDO-dhTFEA restores hypertension (MAP), increases Nrf2 and expression of its target genes, attenuates activation of NF-κB and transforming growth factor-β pathways, and reduces glomerulosclerosis, interstitial fibrosis and inflammation in the chronic kidney disease (CKD) rats[2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: RTA dh404. CAS No. 1191265-33-4. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-112671. | |
| CDDO-DhTFEA | CDDO-DhTFEA can effectively activate Nrf2 and inhibit the pro-inflammatory transcription factor NF-κB. Synonyms: RTA Dh404; RTA Dh404RTA Dh404. CAS No. 1191265-33-4. Molecular formula: C33H45F3N2O3. Mole weight: 574.7. | |
| CDDO-EA | CDDO-EA is an activator of Nrf2/ARE. It has neuroprotective effect. Synonyms: CDDO ethyl amide; RTA405; TP319; RTA 405; TP 319; RTA-405; TP-319. Grade: >98%. CAS No. 932730-51-3. Molecular formula: C33H46N2O3. Mole weight: 518.73. | |
| CDDO-EA | CDDO-EA is an NF-E2 related factor 2/antioxidant response element (Nrf2/ARE) activator. Uses: Scientific research. Category: Signaling pathways. Alternative Names: CDDO ethyl amide; TP319; RTA 405. CAS No. 932730-51-3. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-12213. | |
| CDDO Im | CDDO Im. Group: Biochemicals. Grades: Purified. CAS No. 443104-02-7. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| CDDO-Im | CDDO-Im (RTA-403) is an activator of Nrf2 and PPAR, with Kis of 232 and 344 nM for PPARα and PPARγ[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: RTA-403; TP-235; CDDO-Imidazolide. CAS No. 443104-02-7. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-15725. | |
| CDDO Imidazolide | CDDO Imidozolide is a synthetic triterpenoid as a Nrf2 signaling activator with highly active in suppressing cellular proliferation of human leukemia and breast cancer cell. Uses: Nrf2 signaling activator. Synonyms: 1-(2-Cyano-3,12,28-trioxooleana-1,9(11)-dien-28-yl)-1H-imidazole; (4aR,6aR,6aS,6bR,8aS,12aS,14bS)-8a-(imidazole-1-carbonyl)-4,4,6a,6b,11,11,14b-heptamethyl-3,13-dioxo-4a,5,6,6a,7,8,9,10,12,12a-decahydropicene-2-carbonitrile. Grade: ≥98 %. CAS No. 443104-02-7. Molecular formula: C34H43N3O3. Mole weight: 541.72. | |
| CDDO Imidazolide | CDDO Imidozolide (CDDO-Im) is a synthetic triterpenoid CDDO-Im inhibits fatty acid synthase expression and has antiproliferative and proapoptotic effects in human liposarcoma cells. Studies show that CDDO-Im is highly active in suppressing cellular proliferation of human leukemia and breast cancer cell lines as well as being an effective therapeutic agent in the treatment of other types of cancers. Group: Biochemicals. Alternative Names: 1-(2-Cyano-3,12,28-trioxooleana-1,9(11)-dien-28-yl)-1H-imidazole; 2-Cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid imidazolide; CDDO-Im; RTA 403; TP 235. Grades: Highly Purified. CAS No. 443104-02-7. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| CDDO-TFEA | CDDO-TFEA is an Nrf2/ARE pathway activator. CDDO-TFEA inhibits BACH1 via reducing BACH1 nuclear levels while accumulating its cytoplasmic form. Synonyms: 2-cyano-3,12-dioxo-N-(2,2,2-trifluoroethyl)-oleana-1,9(11)-dien-28-amide; CDDO-trifluoroethyl-amide. CAS No. 932730-52-4. Molecular formula: C33H43F3N2O3. Mole weight: 572.7. | |
| CDDU-Me | CDDU-Me is an activator of the Nrf2 pathway, which induces the expression of cytoprotective genes regulated by Nrf-2 in vivo. It has anti-inflammatory, anti-tumor and cell protection properties. Synonyms: AC-31539. CAS No. 1616932-17-2. Molecular formula: C32H43NO4. Mole weight: 505.7. | |
| C-Demethyl clethodim | C-Demethyl clethodim. Group: Biochemicals. Alternative Names: (E) -2-[1-[[ (3-Chloro-2-propenyl) oxy]imino]ethyl]-5-[2- (ethylthio) propyl]-1, 3-cyclohexanedione. Grades: Highly Purified. CAS No. 112301-96-9. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C16H24ClNO3S. US Biological Life Sciences. | Worldwide |
| C-Desmethyl Metoprolol | A new byproduct detected in Metoprolol tartrate. Group: Biochemicals. Alternative Names: 1-(Ethylamino)-3-[4-(2-methoxyethyl)phenoxy]-2-propanol; H 173/09. Grades: Highly Purified. CAS No. 109632-08-8. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| CDH11-IN-1 | CDH11-IN-1 is a CDH11 inhibitor. CDH11-IN-1 regulates CDH11-mediated biological pathways. CDH11-IN-1 can be used for research on cancer and rheumatoid arthritis[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1239467-61-8. Pack Sizes: 10 mM * 1 mL in DMSO; 25 mg; 50 mg; 100 mg. Product ID: HY-177575. | |
| c-di-2'-d-2''-O-Me-AMP | c-di-2'-d-2''-O-Me-AMP is an analogue of c-diAMP, the bacterial second messenger. Synonyms: 2'- Deoxy- 2''- O- methyl- cyclic diadenosine monophosphate, sodium salt. Grade: ≥ 95% by HPLC. Molecular formula: C21H26N10O11P2 (free acid). Mole weight: 656.5 (free acid). | |
| c-di-2'-dAMP | c-di-2'-dAMP is an analogue of c-diAMP, the bacterial second messenger. Synonyms: 2'- Deoxy- cyclic diadenosine monophosphate, sodium salt. Grade: ≥ 95% by HPLC. Molecular formula: C20H24N10O11P2 (free acid). Mole weight: 642.4 (free acid). | |
| c-di-2'-dGMP | c-di-2'-dGMP is an analogue of c-diGMP, the bacterial second messenger, which can be used to study ligand-receptor interactions. Synonyms: 2'- Deoxy- cyclic diguanosine monophosphate, sodium salt. Grade: ≥ 95% by HPLC. CAS No. 132182-18-4. Molecular formula: C20H24N10O13P2 (free acid). Mole weight: 674.4 (free acid). | |
| c-di-AMP | c-di-AMP is an agonist of stimulator of interferon genes (STING) for treating cancer. It is a second messenger in bacteria and archaea that is involved in the maintenance of osmotic pressure, response to DNA damage, and control of central metabolism, biofilm formation, acid stress resistance, and other functions. Synonyms: Cyclic diadenylate monophosphate; Cyclic diadenylate; Adenylic acid, cyclic ester; 3',5'-Cyclic diadenylic acid; Cyclic di-3',5'-adenylate; Cyclic di-AMP; Cyclic-di-AMP; Cyclic diadenosine monophosphate; (2R,3R,3aS,7aR,9R,10R,10aS,14aR)-2,9-bis(6-amino-9H-purin-9-yl)-3,5,10,12-tetrahydroxyoctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9]tetraoxa[2,8]diphosphacyclododecine 5,12-dioxide. Grade: ≥95%. CAS No. 54447-84-6. Molecular formula: C20H24N10O12P2. Mole weight: 658.41. | |
| c-di-AMP diammonium | c-di-AMP diammonium is a STING agonist, which binds to the transmembrane protein STING thereby activating the TBK3-IRF3 signaling pathway, subsequently triggering the production of type I IFN and TNF. c-di-AMP diammonium is also a bacterial second messenger, which regulates cell growth, survival, and virulence, primarily within Gram-positive bacteria, and also regulates host immune response. Synonyms: Cyclic diadenylate diammonium; Cyclic-di-AMP diammonium; 3'-Adenylic acid, adenylyl-(3'→5')-, cyclic nucleotide, diammonium; Adenylic acid, cyclic ester diammonium; 3',5'-Cyclic diadenylic acid diammonium; Cyclic di-3',5'-adenylate diammonium; Cyclic diadenylate monophosphate diammonium; (2R,3R,3aS,7aR,9R,10R,10aS,14aR)-2,9-bis(6-amino-9H-purin-9-yl)-3,5,10,12-tetrahydroxyoctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9]tetraoxa[2,8]diphosphacyclododecine 5,12-dioxide diammonium. Grade: ≥95%. Molecular formula: C20H30N12O12P2. Mole weight: 692.47. | |
| c-di-AMP disodium | c-di-AMP disodium. CAS No. 2734909-87-4. Purity: HPLC > 97%. Product ID: ACM-ONT2734909874. Molecular formula: C20H22N10Na2O12P2. Mole weight: 702.38. Alfa Chemistry - ISO 9001:32057 Certified. |  |
Our database is helping our users find suppliers everyday.
